POU3F3

Chr 2AD

POU class 3 homeobox 3

Also known as: BRN1, OTF8, SNIBFIS, brain-1, oct-8

This gene encodes a POU-domain containing protein that functions as a transcription factor. The encoded protein recognizes an octamer sequence in the DNA of target genes. This protein may play a role in development of the nervous system. [provided by RefSeq, Apr 2015]

OMIMResearchGenerating clinical summary…
MultiplemechanismADLOEUF 0.431 OMIM phenotype
Clinical SummaryPOU3F3
🧬
Gene-Disease Validity (ClinGen)
complex neurodevelopmental disorder · ADDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Moderately constrained gene (pLI 0.88) — some intolerance to loss-of-function variants.
📋
ClinVar Variants
55 unique Pathogenic / Likely Pathogenic· 151 VUS of 246 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint?
0.43LOEUF
pLI 0.883
Z-score 2.45
OE 0.00 (0.000.43)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?
3.04Z-score
OE missense 0.36 (0.290.44)
63 obs / 176.8 exp
Mild constraint

Moderately missense-constrained (top ~2.5%)

Observed / Expected Ratios?
LoF OE?0.00 (0.000.43)
00.351.4
Missense OE?0.36 (0.290.44)
00.61.4
Synonymous OE?1.08
01.21.6
LoF obs/exp: 0 / 7.0Missense obs/exp: 63 / 176.8Syn Z: -0.60
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitivePOU3F3-related intellectual disabilityOTHERAD

This gene — mechanism propensity

DN
0.3396th %ile
GOF
0.3193th %ile
LOF
0.90top 5%

This gene has evidence for multiple mechanisms of pathogenicity (loss-of-function and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to loss-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

LOFprediction above median · 1 literature citation · 56% of P/LP variants are LoF · LOEUF 0.43
GOF1 literature citation

Literature Evidence

GOFGain-of-function assays showed that the overexpression of lncRNA POU3F3 maintained cell survival with DTIC treatment, while the knockdown of lncRNA POU3F3 restored cell sensitivity to DTIC.1
LOFIn this paper, we discuss the possible role of POU3F3 haploinsufficiency in relation to the boy's phenotype.2

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

246 submitted variants in ClinVar

Classification Summary

Pathogenic16
Likely Pathogenic39
VUS151
Likely Benign36
Benign3
Conflicting1
16
Pathogenic
39
Likely Pathogenic
151
VUS
36
Likely Benign
3
Benign
1
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
14
2
0
0
16
Likely Pathogenic
17
22
0
0
39
VUS
3
143
5
0
151
Likely Benign
0
11
3
22
36
Benign
0
1
1
1
3
Conflicting
1
Total34179923246

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

16 pathogenic / likely-pathogenic (of 26) ClinVar copy-number / structural variants overlap POU3F3 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

POU3F3 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →